Immeasurable
VC Fund
West Hollywood, United States
Immeasurable is a VC fund in West Hollywood focused on Software and Health Care. Immeasurable creates companies and invests in founders and fund managers. These partnerships aim to drive innovation and foster growth in various industries, ultimately contributing to a more dynamic economy. By focusing on visionary leaders, Immeasurable seeks to build a portfolio of transformative businesses that can make a lasting impact.
- Total investments:
- 23
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Immeasurable invests in
Stages Immeasurable invests in
Countries Immeasurable invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
4 more contacts available
Round size
- Seed
- $500k–$4.3M
- Pre-Seed
- $125k–$3.8M
Investment Focus
Industry
- Software 6 (26%)
- Health Care 5 (22%)
- Artificial Intelligence 4 (17%)
- SaaS 3 (13%)
- E-Commerce 3 (13%)
Stage
- Seed 19 (83%)
- Pre-Seed 4 (17%)
Country
- United States 15 (65%)
- Nigeria 2 (9%)
- Canada 1 (4%)
- Georgia 1 (4%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Blaine Vess
Founder
|
Founder | Total investments: 49 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
PrintFriendly was born out of our founder’s desire to simplify the process of cleanly printing online content and converting web pages to PDFs. We don’t use printers as much these days, and PDFs have emerged as one of the most popular file formats in the world, so now we're all in on PDFs.At PrintFriendly, we continue to make it easy toprint web pages and convert them to PDFs, while also offering PDF compression, other PDF conversion options, and the convenience of signing PDFs online. | Seed / Apr 10, 2023 | |
|
|
Over the last decade, our team has built and scaled content channels in some of the most competitive verticals (ex. insurance, personal loans, b2b SaaS). Today, we are building a toolset for content teams to scale their content channels faster and drive more traffic from organic search. | $2.6M / Seed / Feb 01, 2023 | |
|
|
Automated quantity takeoff software for construction cost estimators | Seed / Jan 01, 2023 | |
|
|
Flowbo is a funding platform for online content creators that provides financial services. The company was founded in 2021 and is headquartered in Los Angeles, California, United States. | Seed / Jan 01, 2023 | |
|
|
Parallel Bio develops tools that help in the discovery and development of immunotherapies, to eliminate current barriers and create the fastest path to a drug that works. Parallel Bio's platform combines best-in-class human immune organoids with computational methods to generate unprecedented insights into human health and disease. | $4.3M / Seed / Dec 20, 2022 | |
|
|
SFA Therapeutics is a development-stage bio-pharmaceutical startup company focused on a new advancement in the treatment of chronic inflammatory disease - the use of microbiome-derived metabolites as drugs. | $4M / Seed / Jun 20, 2022 | |
|
|
PathMatch's career navigation app (think Waze for your Career) helps college students navigate their way to a great career by connecting them to the modern career paths, skills, and experience employers look for. | $2.2M / Pre-Seed / Mar 27, 2022 | |
|
|
Mindstate Design Labs is a clinical-stage AI neuroengineering platform developing novel psychoactive drug classes for psychiatric disease indications. The company's Osmanthus ensemble of AI models maps the molecular biology of human emotional and cognitive states by integrating the world’s largest datasets of psychoactive pharmacology andsubjective experience. Mindstate's lead program MSD-001 received FDA and EMA approval for Phase I human trials in 2024.Mindstate Design Labs is a Y Combinator company backed by Initialized Capital and other top-tier investors including the founders of OpenAI, Neuralink, Coinbase, Instacart, AngelList, Twitch, and IVADO. The company was founded by biotech venture investor & serial operator Dillan DiNardo and by computer scientist & evolutionary biologist Dr. Thomas Ray, who is famous for instantiating biological phenomena in emergent machine learning systems. | $11.5M / Seed / Feb 10, 2022 | |
|
|
Semblance is a retailer of a non-alcoholic sparkling wine to enjoy anytime. | Seed / Jan 01, 2022 | |
|
|
Builtfirst allows any company can create a perk marketplace, integration marketplace, reseller marketplace, or service marketplace in minutes. Our mission is to create the largest ecosystem of marketplace partners any company can go to market through. | $3.8M / Pre-Seed / Dec 20, 2021 | |
| See all 23 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does Immeasurable invest in?
Immeasurable invests primarily in Software, Health Care and Artificial Intelligence startups, most often at Seed and Pre-Seed stage. Most of the 23 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Immeasurable's check size?
Immeasurable typically joins rounds of $500k–$4.3M at Seed and $125k–$3.8M at Pre-Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Immeasurable participates in.
How do I contact Immeasurable?
Public channels for Immeasurable include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Immeasurable?
The team at Immeasurable includes Blaine Vess (Founder). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!